Agenda - Management Board meeting: 30 September 2026
Submitted by Anonymous (not verified) on 6 October 2026 - 15:15
Agenda - Management Board meeting: 30 September 2026
Agenda - Management Board meeting: 30 September 2026
Management Board meeting: 30 September 2026, European Medicines Agency, Amsterdam, the Netherlands, 30 September 2026
Agenda - Management Board meeting: 30 September 2026
PSUSA/00001584/202602
PSUSA/00001955/202602
PSUSA/00001248/202602
European Medicines Agency workshop on bacteriophage therapy, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 October 2026, 09:00 (CET) to 30 October 2026, 18:00 (CET)
Human medicines European public assessment report (EPAR): Usymro, ustekinumab, Date of authorisation: 14/08/2025, Revision: 4, Status: Authorised
PSUSA/00001583/202602
PSUSA/00001781/202601